Literature DB >> 27012317

Epidemiology, Evolution, and Long-Term Survival of Alcoholic Cirrhosis Patients Submitted to Liver Transplantation in Southeastern Spain.

Isabel Legaz1,2, Elena Navarro-Noguera3, Jose M Bolarín1, Ana M García-Alonso1, Aurelio Luna Maldonado2, Anna Mrowiec1, Jose A Campillo1, Lourdes Gimeno1, Rosa Moya-Quiles1, Maria Del Rocio Álvarez-López1, Alfredo Minguela Puras1, Manuel Miras3, Francisco Sánchez-Bueno3, Manuel Muro1.   

Abstract

BACKGROUND: Alcoholic cirrhosis (AC) is a common cause of death among individuals abusing alcohol. In the last resort, liver transplantation (LT) is considered the only solution to save the patient's life, generating socioeconomic and public health problems. Clinical and sociodemographic characteristics, rejection frequency, and short- and long-term graft survival are not well known in end-term AC patients undergoing LT. The aim was to determine the sociodemographic and clinical characteristics, their incidence in LT, main pre- and posttransplant complications, and short- and long-term post-transplant graft survival in AC patients in southeastern Spain.
METHODS: The medical records of 1,026 patients who underwent LT over the last 23 years were retrospectively reviewed, and demographic data and posttransplant survivals were analyzed and compared. Biochemical characteristics, major pre- and posttransplant complications and short- and long-term survivals were analyzed in a total of 398 male patients with AC undergoing LT.
RESULTS: AC and viral cirrhosis are the main indications for LT in our study. Mostly represented in our study are AC men without associated viral infections with a mean age of 53.06 years. Main pretransplant complications in AC patients are ascites (78.3%) and encephalopathy (43.5%), while acute graft rejection is the most common liver posttransplant complication (26.6%), nevertheless with low graft loss frequency (1.1%). AC and autoimmune cirrhosis show the best posttransplant survival in both the short and long term. Patients with AC included on the waiting list for LT were Child-Pugh class B (52.1%) and Model for End-Stage Liver Disease score of 10 to 19 (71.2%). The highest percentage of AC patient survival was observed at 1 year posttransplant (81.2%) and progressively decreased over time up to 10 years posttransplant (69.6%). Pretransplant complications such as ascites and encephalopathy did not have an influence on the percentage of posttransplant survivals, although better survival rates were observed in nonviral AC patients.
CONCLUSIONS: AC without viral infections is the main indication for LT in southeastern Spain although its frequency has decreased in last decade. AC is a good indication for LT for its high survival rate and few posttransplant complications. Despite having a high percentage of pretransplant complications (ascites and encephalopathy) but does not appear to influence survivals being observed posttransplant survival rates above those expected. Conversely, viral infections in the patient with AC decrease patient survivals. The main future goals are design new strategies to detect, treat, and reduce AC frequency in our population and know alcoholic recidivism rate posttransplant in our population.
Copyright © 2016 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol; Alcoholic Cirrhosis; Child-Pugh; Liver Rejection; Liver Transplant; Model for End-Stage Liver Disease; Survival

Mesh:

Year:  2016        PMID: 27012317     DOI: 10.1111/acer.13013

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  7 in total

1.  Optimizing strategies to reduce alcohol consumption and relapses, improving abstinence in liver transplant recipients.

Authors:  Isabel Legaz; Manuel Muro
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 7.293

2.  KIR2DL2/S2 and KIR2DS5 in alcoholic cirrhotic patients undergoing liver transplantation.

Authors:  Isabel Legaz; Jose Miguel Bolarín; Elena Navarro; Jose Antonio Campillo; Rosa Moya; María Dolores Pérez-Cárceles; Aurelio Luna; Eduardo Osuna; Manuel Miras; Manuel Muro; Alfredo Minguela; Rocio Alvarez López
Journal:  Arch Med Sci       Date:  2019-04-09       Impact factor: 3.318

3.  Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease.

Authors:  Isabel Legaz; Jose M Bolarin; Jose A Campillo; Rosa M Moya; Aurelio Luna; Eduardo Osuna; Alfredo Minguela; Francisco Sanchez-Bueno; Maria Rocio Alvarez; Manuel Muro
Journal:  Arch Med Sci       Date:  2019-06-18       Impact factor: 3.318

4.  Analysis of hepatitis C virus-positive organs in liver transplantation.

Authors:  Isabel Legaz; Manuel Muro
Journal:  World J Hepatol       Date:  2022-09-27

5.  Causes of Death and Survival in Alcoholic Cirrhosis Patients Undergoing Liver Transplantation: Influence of the Patient's Clinical Variables and Transplant Outcome Complications.

Authors:  J M Bolarín; M D Pérez-Cárceles; J P Hernández Del Rincón; A Luna; A Minguela; M Muro; I Legaz
Journal:  Diagnostics (Basel)       Date:  2021-05-27

6.  Influence of Preformed Antibodies in Liver Transplantation.

Authors:  Isabel Legaz; Francisco Boix; Manuela López; Rafael Alfaro; José A Galián; Santiago Llorente; Jose A Campillo; Carmen Botella; Pablo Ramírez; Francisco Sánchez-Bueno; José A Pons; María R Moya-Quiles; Alfredo Minguela; Manuel Muro
Journal:  J Clin Med       Date:  2020-03-05       Impact factor: 4.241

7.  Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients.

Authors:  F Boix; I Legaz; A Minhas; R Alfaro; V Jiménez-Coll; A Mrowiec; H Martínez-Banaclocha; J A Galián; C Botella; M R Moya-Quiles; F Sanchez-Bueno; R Robles; J de la Peña-Moral; P Ramirez; J A Pons; A Minguela; M Muro
Journal:  Clin Exp Immunol       Date:  2020-10-29       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.